Streetbeat News

Revenues

AFMD

Affimed N.V. announced the acceptance of an abstract on preclinical data of its CD16A/CD123-targeting innate cell engager, AFM28, for presentation at the EHA 2024 Congress. The data demonstrates AFM28's effectiveness in controlling tumor growth and reducing leukemic blasts and stem cells in AML models.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 2:12 pm

DVAX

The FDA declined to approve Dynavax Technologies Corporation's (DVAX) supplemental Biologics License Application for a four-dose HEPLISAV-B vaccine regimen for adults on hemodialysis, citing insufficient data. The decision does not affect the current approvals of HEPLISAV-B in the U.S., EU, and Great Britain, nor the recent approval in the EU for the hemodialysis population. Dynavax intends to meet with the FDA to discuss additional data support. Despite this, HEPLISAV-B's net product revenue increased, and its U.S. market share grew in the first quarter of 2024.

Portfolio Pulse from Vandana Singh

May 14, 2024 | 2:10 pm

SPY

Fed Chair Powell highlighted the lack of progress on U.S. inflation in Q1, emphasizing the need for patience and allowing policy to take effect. He expects continued GDP growth of 2% or better and anticipates inflation to decrease to levels similar to last year, though his confidence in this prediction has diminished.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 2:09 pm

SPY

Fed Chair Powell highlighted the strong performance of the U.S. economy, emphasizing a robust labor market, financially healthy households, and strong consumer spending and business investment.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 2:06 pm

AUTL

Autolus Therapeutics plc (NASDAQ:AUTL) announced the online publication of three abstracts on obe-cel for treating relapsed/refractory B-Cell Acute Lymphoblastic Leukemia, to be presented at the EHA Congress in June 2024.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 2:05 pm

BJ

BJ's Wholesale Club (NYSE:BJ) has been the subject of diverse analyst ratings over the last three months, with a total of 13 analysts offering opinions ranging from bullish to bearish. Recent updates show a shift towards a more positive outlook, with the average 12-month price target for BJ's stock rising to $81.62 from $77.00, a 6.0% increase. Analyst actions include both upgrades and downgrades, with price targets ranging from $62.00 to $92.00. The company has shown solid financial performance, including revenue growth of 8.68% as of January 31, 2024, a net margin of 2.72%, and an ROE of 10.37%, despite a high debt-to-equity ratio of 2.05.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 2:02 pm

OWL

Blue Owl Cap (NYSE:OWL) received diverse analyst ratings over the last three months, with a total of 9 evaluations ranging from bullish to bearish. The average 12-month price target for OWL is now $21.72, up 7.68% from the previous $20.17, with a high estimate of $24.00 and a low of $19.00. Analyst actions include ratings adjustments and price target changes, reflecting dynamic market conditions and company performance. Blue Owl Capital, an alternative asset management firm, shows a positive revenue trend with a 31.29% growth rate as of March 31, 2024, but faces challenges in net margin, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 2:01 pm

SPSC

SPS Commerce (NASDAQ:SPSC) has received mixed analyst ratings over the past three months, with a recent shift towards more bullish perspectives. The average 12-month price target for SPSC has been raised to $207.67, indicating a positive outlook from analysts. Key financial indicators show SPS Commerce with strong revenue growth, net margin, ROE, and ROA, alongside low debt levels, suggesting a robust financial performance.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 2:01 pm

TRNO

Recent analyst ratings for Terreno Realty (NYSE:TRNO) show a mix of bullish and neutral perspectives, with an updated average 12-month price target of $66.14, reflecting a 4.44% increase from the previous target. Analyst actions include ratings adjustments and price target changes by firms such as Goldman Sachs, JMP Securities, Mizuho, Wedbush, Barclays, and Piper Sandler. Terreno Realty, a real estate investment trust, has demonstrated strong financial performance with notable revenue growth, net margin, ROE, and ROA, outperforming industry averages.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 2:00 pm

KIQ

Kelso Technologies (AMEX:KIQ) reported a Q1 EPS of $(0.01), unchanged YoY, with sales increasing 7.83% to $2.65M from $2.46M YoY.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 1:13 pm